Since the approval of DPP4 inhibitors for treatment of T2DM, the interest on alternate physiological effects of the enzyme and on context-sensitive association of DPP4 features with diabetes and other conditions has increased (8,10). This evidence concerns the gene DPP4 and type 2 diabetes mellitus.